Gouirand V, Rosenblum MD PMID: 34597122

063 A new case series of Olmsted syndrome subjects confirms EGFR activation and shows remarkable efficacy of targeted systemic EGFR inhibition with acceptable side effects.

J. Basset, Y. Diab, F. Santiago, L. Azulay, K. Cordoro, A. Zhang, A. Kirkorian, F. Bradley, F. Watanabe, D. Siegel, E. Bourrat, R. Howard, A. Hovnanian PMID:
Silverberg JI, Hou A, Warshaw EM, Maibach HI, Belsito DV, DeKoven JG, Zug KA, Taylor JS, Sasseville D, Fransway AF, DeLeo VA, Pratt MD, Reeder MJ, Atwater AR, Fowler JF, Zirwas MJ, Marks JG, Dunnick CA, Houle MC PMID: 34582838
Bajwa H, Baghchechi M, Mujahid M, Kang Dufour MS, Langan SM, Abuabara K PMID: 34547359
Naik HB, Alhusayen R, Frew J, Guilbault S, Hills NK, Ingram JR, Kudlinski MV, Lowes MA, Marzano AV, Paul M, Villumsen B, Yannuzzi CA PMID: 34537252